Leishmania donovani BPK282A1 complete genome, chromosome 2.
Eukaryota; Euglenozoa; Kinetoplastida; Trypanosomatidae; Leishmaniinae; Leishmania.
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
Submitted (30-MAR-2018) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA
Submitted (25-JAN-2011) Aslett M., Pathogen Sequencing Unit, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, Cambridgeshire CB10 1SA, UNITED KINGDOM
PROVISIONAL REFSEQ: This record has not yet been subject to final\nNCBI review. The reference sequence is identical to FR799589.\nData release policy http://www.sanger.ac.uk/legal/#t_2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: INSDC submitter\nAnnotation Status :: Full annotation\nAnnotation Pipeline :: Eukaryotic Annotation Propagation Pipeline\n##Genome-Annotation-Data-END##
phosphatidylinositol 3-kinase-like protein
phosphoglycan beta 1,3 galactosyltransferase
phosphoglycan beta 1,2 arabinosyltransferase
small GTP binding protein rab6-like protein
ribosomal RNA processing protein, putative
proteasome regulatory non-ATPase subunit 6, putative
ubiquitin-conjugating enzyme e2, putative
RNA-editing complex protein MP81, putative
gamma-glutamyl phosphate reductase-like protein
ATP-dependent Clp protease subunit, heat shock protein 78 (HSP78), putative
dehydrogenase/oxidoreductase-like protein